Download PDF
Neuropediatrics 2006; 37(2): 102-106
DOI: 10.1055/s-2006-923981
Short Communication

Georg Thieme Verlag KG Stuttgart · New York

Movement Disorders Induced by Gastrointestinal Drugs: Two Paediatric Cases

J. Elzinga-Huttenga1 , Y. Hekster2 , A. Bijl3 , J. Rotteveel1
  • 1Department of Paediatric Neurology, University Medical Centre St Radboud, Nijmegen, The Netherlands
  • 2Department of Clinical Pharmacy, University Medical Centre St Radboud, Nijmegen, The Netherlands
  • 3Netherlands Pharmacovigilance Centre, Lareb, ‘s-Hertogenbosch, The Netherlands
Further Information

Publication History

Received: May 3, 2005

Accepted after Revision: February 6, 2006

Publication Date:
14 June 2006 (online)

    Permissions and Reprints

Abstract

A number of frequently prescribed gastrointestinal drugs can cause movement disorders in children, as well as in adults. In our centre for paediatric neurology, we saw a 3-year-old girl with abnormal movements mostly of the legs with an inner restlessness (akathisia) while using cisapride. Another patient, a 17-year-old male, developed a hemiballism (a fierce movement of one arm and shoulder with a hurling appearance) while using ranitidine for gastric distress. In both children, the movement disorder disappeared after discontinuing the drug. The pathophysiological mechanisms of these drug-induced movement disorders might be related to the central function of histamine in the developing brain. These cases illustrate the importance of being alert for possible drug-induced events early in the process of diagnosing abnormal movement disorders.

Key words

Movement disorder - drug - gastrointestinal - H2 receptor antagonists - cisapride - adverse drug reactions

References

  • 1 Angelina L, Zorzi G, Rumi V, Nardocci N, Mennini T. Transient paroxysmal dystonia in an infant possibly induced by cisapride.  Ital J Neurological Schi. 1996;  17 157-159
    PubMedGoogle Scholar
  • 2 Belforte J E, Magarinos-Azcone C, Armando I, Buno W, Pazo J H. Pharmacological involvement of the calcium channel blocker flunarizine in dopamine transmission at the striatum.  Parkinsonism & Related Disorders. 2001;  8 33-40
    PubMedGoogle Scholar
  • 3 Bhanji N H, Margolese H C. Extrapyramidal symptoms related to adjunctive nizatidine therapy in an adolescent receiving quetiapine and oparoxetine.  Pharmacotherapy. 2004;  24 923-925
    PubMedGoogle Scholar
  • 4 Blanchet P J. Antipsychotic drug-induced movement disorders.  Can J Neurological Sci. 2003;  30 S101-S107
    PubMedGoogle Scholar
  • 5 Brown R E, Stevens D R, Haas H L. The physiology of brain histamine.  Progress in Neurobiology. 2001;  63 637-672
    CrossrefPubMedGoogle Scholar
  • 6 Bucci K K, Haverstick D E, Abercrombie S A. Dystonic-like reaction following cisapride therapy.  J Fam Pract. 1995;  40 86-88
    PubMedGoogle Scholar
  • 7 Daniel J R, Mauro V F. Extrapyramidal symptoms associated with calcium-channel blockers.  Ann Pharmacother. 1995;  29 73-75
    PubMedGoogle Scholar
  • 8 Debontridder O. Extrapyramidal reactions due to domperidone.  Lancet. 1980;  2 802
    PubMedGoogle Scholar
  • 9 Gerber P E, Lynd L D. Selective serotonin-reuptake inhibitor-induced movement disorders.  Ann Pharmacother. 1998;  32 692-698
    CrossrefPubMedGoogle Scholar
  • 10 Harten P N. Acathisie als bijwerking van geneesmiddelen.  Ned Tijdschr Geneeskd. 2002;  146 110-114
    PubMedGoogle Scholar
  • 11 Karlstedt K, Senkas A, Ahman M, Panula P. Regional expression of the histamine H2 receptor in adult and developing rat brain.  Neuroscience. 2001;  102 210-208
    PubMedGoogle Scholar
  • 12 Kim J, Lee B C, Park H, Ahn Y M, Kang U G, Kim Y S. Subjective emotional experience and cognitive impairment in drug-induced akathisia.  Compr Psychiatry. 2002;  43 456-462
    CrossrefPubMedGoogle Scholar
  • 13 Le-Doze F, Moulin M, Defer G L. Meige's syndrome in a patient treated with ranitidine.  Movement Disorders. 1999;  14 175-176
    CrossrefPubMedGoogle Scholar
  • 14 Lehman A B. Reversible chorea due to ranitidine and cimetidine.  Lancet. 1988;  2 158
    PubMedGoogle Scholar
  • 15 Lucena R, Monteiro L, Melo A. Cisapride related movement disorders.  J Pedaitr (Rio J). 1998;  74 416-418
    PubMedGoogle Scholar
  • 16 Meyboom R HB, Huijbers W AR. Acute extrapiramidale bewegingsstoornissen bij jonge kinderen en bij volwassenen tijdens het gebruik van domperidon.  Ned Tijdschr Geneeskd. 1988;  132 1981-1983
    PubMedGoogle Scholar
  • 17 Miller L G, Jankovic J. Drug-induced dyskinesias: an overview. Joseph AB, Young RR Movement Disorders in Neurology and Psychiatry. Malden, MA, USA; Blackwall Science 1999: 5-24
    Google Scholar
  • 18 Nausieda P A, Holler W C, Weiner W J, Klawans H L. Chorea induced by oral contraceptives.  Neurology. 1979;  12 1605-1609
    PubMedGoogle Scholar
  • 19 Nochimson G. Toxicity, medication-induced dystonic reactions [online]. Available at: www.emedicine.com . 2001
    Google Scholar
  • 20 Ozdemir V, Basile V, Masselis M, Kennedy J L. Pharmacogenetic assesment of antipsychotic-induced movement disorders: contribution of the dopamine D3 receptor and cytochrome P450 1A2.  J Biochem Biophys Methods. 2001;  47 151-157
    CrossrefPubMedGoogle Scholar
  • 21 Piccolo I, Sterzi R, Thiella G, Minazzi M S, Caraceni T. Sporadic choreas: analysis of a general hospital series.  Eur Neurol. 1999;  41 143-149
    CrossrefPubMedGoogle Scholar
  • 22 Pollizi A, Incorpora G, Ruggieri M. Dystonia as acute adverse reaction to cough suppressant in a 3-year-old girl.  Eur J Pediatr Neurol. 2001;  5 167-168
    CrossrefPubMedGoogle Scholar
  • 23 Pranzatelli M R, Albin R L, Cohen B H. Acute dyskinesias in young asthmatics treated with theophylline.  Pediatr Neurol. 1991;  7 216-219
    CrossrefPubMedGoogle Scholar
  • 24 Rodnitzky R L. Drug-induced movement disorders.  Clin Neuropharmacol. 2002;  25 142-152
    PubMedGoogle Scholar
  • 25 Sempere A P, Duarte J, Cabezas C, Claveria L E, Coria F. Aggrevation of parkinson tremor by cisapride.  Clin Neuropharmacol. 1995;  18 76-78
    PubMedGoogle Scholar
  • 26 Senecky Y, Lobel D, Diamond G W, Weitz R, Inbar D. Isolated orofacial dyskinesia: methylphenidate-induced movement disorder.  Pediatr Neurol. 2002;  27 224-226
    CrossrefPubMedGoogle Scholar
  • 27 Smaga S. Tremor.  Am Fam Physician. 2003;  68 1545-1552
    PubMedGoogle Scholar
  • 28 Sol P, Pelet B, Guignard J P. Extrapyramidal reactions due to domperidone.  Lancet. 1980;  2 802
    PubMedGoogle Scholar

MD, PhD J. Rotteveel

Department of Paediatric Neurology
University Medical Centre St Radboud
Geert Grooteplein 10

P. O. Box 9101

6500 HB Nijmegen

The Netherlands

Email: j.rotteveel@cukz.umcn.nl

      >